{"id":"https://openalex.org/W2761669428","doi":"https://doi.org/10.1111/apt.14388","title":"Angiotensin receptor blocker use and gastro\u2010oesophageal cancer survival: a population\u2010based cohort study","display_name":"Angiotensin receptor blocker use and gastro\u2010oesophageal cancer survival: a population\u2010based cohort study","alternate_titles":[],"publication_year":2017,"publication_date":"2017-11-03","ids":{"openalex":"https://openalex.org/W2761669428","doi":"https://doi.org/10.1111/apt.14388","mag":"2761669428","pmid":"https://pubmed.ncbi.nlm.nih.gov/29105106"},"language":"en","primary_location":{"id":"doi:10.1111/apt.14388","doi":"https://doi.org/10.1111/apt.14388","is_oa":true,"landing_page_url":"https://doi.org/10.1111/apt.14388","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14388","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2761669428"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14388","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035503350","display_name":"John Busby","orcid":"https://orcid.org/0000-0003-4831-7464","observed_orcids":["https://orcid.org/0000-0003-4831-7464"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. Busby","raw_affiliation_strings":["Centre for Public Health, Queen's University Belfast, Belfast, UK"],"raw_orcid":"https://orcid.org/0000-0003-4831-7464","affiliations":[{"raw_affiliation_string":"Centre for Public Health, Queen's University Belfast, Belfast, UK","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012654424","display_name":"\u00dana C. McMenamin","orcid":"https://orcid.org/0000-0002-6391-8893","observed_orcids":["https://orcid.org/0000-0002-6391-8893"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u00da. McMenamin","raw_affiliation_strings":["Centre for Public Health, Queen's University Belfast, Belfast, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Public Health, Queen's University Belfast, Belfast, UK","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069662037","display_name":"Andrew D. Spence","orcid":"https://orcid.org/0000-0001-5026-4758","observed_orcids":["https://orcid.org/0000-0001-5026-4758"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Spence","raw_affiliation_strings":["Centre for Public Health, Queen's University Belfast, Belfast, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Public Health, Queen's University Belfast, Belfast, UK","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108095434","display_name":"Brian T. Johnston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289110261","display_name":"Belfast Health and Social Care Trust","ror":"https://ror.org/02tdmfk69","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1289110261"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. T. Johnston","raw_affiliation_strings":["Belfast Health and Social Care Trust, Belfast, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belfast Health and Social Care Trust, Belfast, UK","institution_ids":["https://openalex.org/I1289110261"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Hughes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Hughes","raw_affiliation_strings":["School of Pharmacy, Clinical and Practice Research Group, Queen's University Belfast, Belfast, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Clinical and Practice Research Group, Queen's University Belfast, Belfast, UK","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044126197","display_name":"Chris R. Cardwell","orcid":"https://orcid.org/0000-0002-2689-4335","observed_orcids":["https://orcid.org/0000-0002-2689-4335"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. R. Cardwell","raw_affiliation_strings":["Centre for Public Health, Queen's University Belfast, Belfast, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Public Health, Queen's University Belfast, Belfast, UK","institution_ids":["https://openalex.org/I126231945"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5035503350"],"corresponding_institution_ids":["https://openalex.org/I126231945"],"apc_list":{"value":5250,"currency":"USD","value_usd":5250},"apc_paid":null,"fwci":1.8184,"has_fulltext":true,"cited_by_count":43,"citation_normalized_percentile":{"value":0.8642465,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"47","issue":"2","first_page":"279","last_page":"288"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.39719998836517334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.39719998836517334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.22349999845027924,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.16200000047683716,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":1.0},{"id":"https://openalex.org/keywords/gastroesophageal-cancer","display_name":"gastroesophageal cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cancer-specific-mortality","display_name":"cancer-specific mortality","score":0.8009999990463257},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.46700000762939453},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.8190000057220459},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.6259999871253967},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.6309999823570251},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8730000257492065},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.34599998593330383}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9604222774505615},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6757142543792725},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6650941371917725},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5531988739967346},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5445204377174377},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.4870069622993469},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.478739470243454},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.4248381555080414},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.41866210103034973},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4176323413848877},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.164280503988266},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.10000687837600708},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.06928613781929016},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003929","descriptor_name":"Diabetic Neuropathies","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003929","descriptor_name":"Diabetic Neuropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003929","descriptor_name":"Diabetic Neuropathies","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007231","descriptor_name":"Infant, Newborn","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/apt.14388","doi":"https://doi.org/10.1111/apt.14388","is_oa":true,"landing_page_url":"https://doi.org/10.1111/apt.14388","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14388","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:29105106","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29105106","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary pharmacology & therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pure.qub.ac.uk/portal:openaire/4a77d78f-0217-420e-86cd-be20866e1c01","doi":null,"is_oa":true,"landing_page_url":"https://pure.qub.ac.uk/en/publications/4a77d78f-0217-420e-86cd-be20866e1c01","pdf_url":null,"source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Busby, J, McMenamin, U, Spence, A, Johnston, B T, Hughes, C & Cardwell, C 2018, 'Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study', Alimentary Pharmacology and Therapeutics, vol. 47, no. 2, pp. 279-288. https://doi.org/10.1111/apt.14388","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/apt.14388","doi":"https://doi.org/10.1111/apt.14388","is_oa":true,"landing_page_url":"https://doi.org/10.1111/apt.14388","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14388","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G4601680249","display_name":null,"funder_award_id":"C54914/A20558","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G5911015135","display_name":null,"funder_award_id":"20100","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G7305402455","display_name":null,"funder_award_id":"20558","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2761669428.pdf","grobid_xml":"https://content.openalex.org/works/W2761669428.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1568390176","https://openalex.org/W1849521086","https://openalex.org/W1943165799","https://openalex.org/W1966339428","https://openalex.org/W1966866954","https://openalex.org/W1969716182","https://openalex.org/W1972113220","https://openalex.org/W1982920623","https://openalex.org/W1985359478","https://openalex.org/W1989217069","https://openalex.org/W1990488038","https://openalex.org/W1993118867","https://openalex.org/W1995582677","https://openalex.org/W1997386973","https://openalex.org/W2001872567","https://openalex.org/W2009428399","https://openalex.org/W2021968441","https://openalex.org/W2026656096","https://openalex.org/W2029384360","https://openalex.org/W2036468190","https://openalex.org/W2038981426","https://openalex.org/W2041084651","https://openalex.org/W2041955995","https://openalex.org/W2048869581","https://openalex.org/W2058823385","https://openalex.org/W2073177214","https://openalex.org/W2082943727","https://openalex.org/W2091446228","https://openalex.org/W2094546405","https://openalex.org/W2103552199","https://openalex.org/W2105473163","https://openalex.org/W2110608811","https://openalex.org/W2119505902","https://openalex.org/W2119852447","https://openalex.org/W2134843796","https://openalex.org/W2135038122","https://openalex.org/W2135069427","https://openalex.org/W2140319788","https://openalex.org/W2146174453","https://openalex.org/W2153706988","https://openalex.org/W2157624452","https://openalex.org/W2168140531","https://openalex.org/W2323982445","https://openalex.org/W2337699335","https://openalex.org/W2398842590","https://openalex.org/W3140388327","https://openalex.org/W3208279890","https://openalex.org/W4237738213","https://openalex.org/W4247938048"],"related_works":["https://openalex.org/W4224280899","https://openalex.org/W4414373597","https://openalex.org/W1976451694","https://openalex.org/W4297831701","https://openalex.org/W4386531209","https://openalex.org/W2084832631","https://openalex.org/W4402273318","https://openalex.org/W2966591448","https://openalex.org/W4377224738","https://openalex.org/W2337539066"],"abstract_inverted_index":{"BACKGROUND:":[0],"Angiotensin":[1],"receptor":[2],"blockers":[3],"(ARBs;":[4],"including":[5],"candesartan,":[6],"losartan,":[7],"olmesartan":[8],"and":[9,19,63,80,90,99,127,134,153],"valsartan)":[10],"are":[11],"widely":[12],"used":[13,110,151],"to":[14,43,88,100,114,157],"treat":[15],"hypertension,":[16],"heart":[17],"failure":[18],"diabetic":[20],"neuropathy.":[21],"There":[22,184],"is":[23,239],"considerable":[24],"pre-clinical":[25],"evidence":[26,186],"that":[27],"ARBs":[28],"can":[29],"reduce":[30],"cancer":[31,52,65,77,84,146,160,173,217],"progression,":[32],"particularly":[33],"for":[34,106,131],"gastric":[35],"cancer.":[36],"Despite":[37],"this,":[38],"epidemiological":[39,233],"studies":[40,234],"have":[41],"yet":[42],"assess":[44],"the":[45,57,94,104,176,192],"impact":[46],"of":[47,72,148,171,187,203],"ARB":[48,61,125,165,226],"use":[49,62],"on":[50],"gastro-oesophageal":[51,64,76,120,145,159,172,216],"survival.":[53,66],"AIM:":[54],"To":[55],"investigate":[56],"association":[58],"between":[59,78,123],"post-diagnosis":[60,124,135],"METHODS:":[67],"We":[68,86,109],"selected":[69],"a":[70,188],"cohort":[71,142],"patients":[73,197],"with":[74,191,235],"newly-diagnosed":[75],"1998":[79],"2012":[81],"from":[82,93,103],"English":[83],"registries.":[85],"linked":[87],"prescription":[89],"clinical":[91],"records":[92,102],"Clinical":[95],"Practice":[96],"Research":[97],"Datalink,":[98],"death":[101],"Office":[105],"National":[107],"Statistics.":[108],"time-dependant":[111],"Cox-regression":[112],"models":[113],"calculate":[115],"hazard":[116],"ratios":[117],"(HRs)":[118],"comparing":[119],"cancer-specific":[121,223],"mortality":[122,174,224],"users":[126,166],"non-users,":[128],"after":[129],"adjusting":[130],"demographics,":[132],"comorbidities":[133],"aspirin":[136],"or":[137],"statin":[138],"use.":[139],"RESULTS:":[140],"Our":[141],"included":[143],"5124":[144],"patients,":[147],"which":[149],"360":[150],"ARBs,":[152],"3345":[154],"died":[155],"due":[156],"their":[158],"during":[161],"follow-up.":[162],"After":[163],"adjustment,":[164],"had":[167],"moderately":[168,221],"lower":[169],"risk":[170],"than":[175],"non-users":[177],"(HR":[178,205],"=":[179,206],"0.83,":[180],"95%":[181,208],"CI":[182,209],"0.71-0.98).":[183],"was":[185],"dose-response":[189],"relationship":[190],"lowest":[193],"HRs":[194],"observed":[195],"among":[196,225],"receiving":[198],"at":[199],"least":[200],"2":[201],"years":[202],"prescriptions":[204],"0.42,":[207],"0.25-0.72).":[210],"CONCLUSIONS:":[211],"In":[212],"this":[213],"large":[214],"population-based":[215],"cohort,":[218],"we":[219],"found":[220],"reduced":[222],"users.":[227],"However,":[228],"confirmation":[229],"in":[230],"further":[231],"independent":[232],"sufficient":[236],"staging":[237],"information":[238],"required.":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2761669428","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2017-10-20T00:00:00"}
